|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bade BC and Dela Cruz CS: Lung cancer
2020: Epidemiology, etiology, and prevention. Clin Chest Med.
41:1–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Velcheti V, Schalper KA, Carvajal DE,
Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L
and Rimm DL: Programmed death ligand-1 expression in non-small cell
lung cancer. Lab Invest. 94:107–116. 2014. View Article : Google Scholar
|
|
4
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du Z, Sun T, Hacisuleyman E, Fei T, Wang
X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW and Liu XS:
Integrative analyses reveal a long noncoding RNA-mediated sponge
regulatory network in prostate cancer. Nat Commun. 7:109822016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Y, Chen L, Gu J, Zhang H, Yuan J,
Lian Q, Lv G, Wang S, Wu Y, Yang YT, et al: Recurrently deregulated
lncRNAs in hepatocellular carcinoma. Nat Commun. 8:144212017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Seiler J, Breinig M, Caudron-Herger M,
Polycarpou-Schwarz M, Boutros M and Diederichs S: The lncRNA veluct
strongly regulates viability of lung cancer cells despite its
extremely low abundance. Nucleic Acids Res. 45:5458–5469. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park SM, Choi EY, Bae DH, Sohn HA, Kim SY
and Kim YJ: The LncRNA EPEL promotes lung cancer cell proliferation
through E2F target activation. Cell Physiol Biochem. 45:1270–1283.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen N, Guo D, Xu Q, Yang M, Wang D, Peng
M, Ding Y, Wang S and Zhou J: Long non-coding RNA FEZF1-AS1
facilitates cell proliferation and migration in colorectal
carcinoma. Oncotarget. 7:11271–11283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu X, Zhang P, Zhu H, Li S, Chen X and Shi
L: Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of
gastric cancer and promotes tumorigenesis via activation of Wnt
signaling pathway. Biomed Pharmacother. 96:1103–1108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Z, Zhao P, Han Y and Lu S: LincRNA
FEZF1-AS1 is associated with prognosis in lung adenocarcinoma and
promotes cell proliferation, migration and invasion. Oncol Res.
27:39–45. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He R, Zhang FH and Shen N: LncRNA
FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through
suppressing E-cadherin and regulating WNT pathway in non-small cell
lung cancer (NSCLC). Biomed Pharmacother. 95:331–338. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou C, Xu J, Lin J, Lin R, Chen K, Kong J
and Shui X: Long noncoding RNA FEZF1-AS1 promotes osteosarcoma
progression by regulating the miR-4443/NUPR1 axis. Oncol Res.
26:1335–1343. 2018.PubMed/NCBI
|
|
19
|
Ye H, Zhou Q, Zheng S, Li G, Lin Q, Ye L,
Wang Y, Wei L, Zhao X, Li W, et al: FEZF1-AS1/miR-107/ZNF312B axis
facilitates progression and Warburg effect in pancreatic ductal
adenocarcinoma. Cell Death Dis. 9:342018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li QY, Chen L, Hu N and Zhao H: Long
non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma
via miR-610/Akt3 axis. Biomed Pharmacother. 103:1727–1732. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) Edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Zhou Y, Zeng P, Li YH, Zhang Z and Cui Q:
SRAMP: Prediction of mammalian N6-methyladenosine (m6A) sites based
on sequence-derived features. Nucleic Acids Res. 44:e912016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Backlund PS Jr, Carotti D and Cantoni GL:
Effects of the S-adenosylhomocysteine hydrolase inhibitors
3-deazaadenosine and 3-deazaaristeromycin on RNA methylation and
synthesis. Eur J Biochem. 160:245–251. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang K, Long B, Zhou LY, Liu F, Zhou QY,
Liu CY, Fan YY and Li PF: CARL lncRNA inhibits anoxia-induced
mitochondrial fission and apoptosis in cardiomyocytes by impairing
miR-539-dependent PHB2 downregulation. Nat Commun. 5:35962014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Ding X, Liu B, Li M, Chang Y, Shen
H, Xie SM, Xing L and Li Y: ETV4 overexpression promotes
progression of non-small cell lung cancer by upregulating PXN and
MMP1 transcriptionally. Mol Carcinog. 59:73–86. 2020. View Article : Google Scholar
|
|
27
|
Fu Y, Dominissini D, Rechavi G and He C:
Gene expression regulation mediated through reversible
m6A RNA methylation. Nat Rev Genet. 15:293–306. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheloufi S, Dos Santos CO, Chong MM and
Hannon GJ: A dicer-independent miRNA biogenesis pathway that
requires Ago catalysis. Nature. 465:584–589. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mao Z, Wu F and Shan Y: Identification of
key genes and miRNAs associated with carotid atherosclerosis based
on mRNA-seq data. Medicine (Baltimore). 97:e98322018. View Article : Google Scholar
|
|
30
|
Li Z, Jia J, Gou J, Tong A, Liu X, Zhao X
and Yi T: Mmu-miR-126a-3p plays a role in murine embryo
implantation by regulating Itga11. Reprod Biomed Online.
31:384–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang TC, Renuse S, Pinto S, Kumar P, Yang
Y, Chaerkady R, Godsey B, Mendell JT, Halushka MK, Civin CI, et al:
Identification of miR-145 targets through an integrated omics
analysis. Mol Biosyst. 11:197–207. 2015. View Article : Google Scholar :
|
|
32
|
Zhang HH and Li AH: Long non-coding RNA
FEZF1-AS1 is up-regulated and associated with poor prognosis in
patients with cervical cancer. Eur Rev Med Pharmacol Sci.
22:3357–3362. 2018.PubMed/NCBI
|
|
33
|
Zhang Z, Sun L, Zhang Y, Lu G, Li Y and
Wei Z: Long non-coding RNA FEZF1-AS1 promotes breast cancer
stemness and tumorigenesis via targeting miR-30a/Nanog axis. J Cell
Physiol. 233:8630–8638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao BS, Roundtree IA and He C:
Post-transcriptional gene regulation by mRNA modifications. Nat Rev
Mol Cell Biol. 18:31–42. 2017. View Article : Google Scholar
|
|
35
|
Dominissini D, Moshitch-Moshkovitz S,
Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K,
Jacob-Hirsch J, Amariglio N, Kupiec M, et al: Topology of the human
and mouse m6A RNA methylomes revealed by m6A-seq. Nature.
485:201–206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alarcon CR, Goodarzi H, Lee H, Liu X,
Tavazoie S and Tavazoie SF: HNRNPA2B1 is a mediator of
m(6)A-dependent nuclear RNA processing events. Cell. 162:1299–1308.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo F, Li Y, Liu Y, Wang J, Li Y and Li G:
Inhibition of metastasis-associated lung adenocarcinoma transcript
1 in CaSki human cervical cancer cells suppresses cell
proliferation and invasion. Acta Biochim Biophys Sin (Shanghai).
42:224–229. 2010. View Article : Google Scholar
|
|
38
|
Patil DP, Chen CK, Pickering BF, Chow A,
Jackson C, Guttman M and Jaffrey SR: m(6)A RNA methylation promotes
XIST-mediated transcriptional repression. Nature. 537:369–373.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takada Y, Ye X and Simon S: The integrins.
Genome Biol. 8:2152007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hegde S and Raghavan S: A skin-depth
analysis of integrins: Role of the integrin network in health and
disease. Cell Commun Adhes. 20:155–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tiger CF, Fougerousse F, Grundström G,
Velling T and Gullberg D: alpha11beta1 integrin is a receptor for
interstitial collagens involved in cell migration and collagen
reorganization on mesenchymal nonmuscle cells. Dev Biol.
237:116–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chai J, Modak C, Ouyang Y, Wu SY and Jamal
MM: CCN1 induces ß-catenin translocation in esophageal squamous
cell carcinoma through integrin a11. ISRN Gastroenterol.
2012:2072352012. View Article : Google Scholar
|
|
43
|
Parajuli H, Teh MT, Abrahamsen S,
Christoffersen I, Neppelberg E, Lybak S, Osman T, Johannessen AC,
Gullberg D, Skarstein K and Costea DE: Integrin a11 is
overexpressed by tumour stroma of head and neck squamous cell
carcinoma and correlates positively with alpha smooth muscle actin
expression. J Oral Pathol Med. 46:267–275. 2017. View Article : Google Scholar
|
|
44
|
Reigstad I, Smeland HY, Skogstrand T,
Sortland K, Schmid MC, Reed RK and Stuhr L: Stromal integrin a11ß1
affects RM11 prostate and 4T1 breast xenograft tumors differently.
PLoS One. 11:e01516632016. View Article : Google Scholar
|
|
45
|
Zhu CQ, Popova SN, Brown ER,
Barsyte-Lovejoy D, Navab R, Shih W, Li M, Lu M, Jurisica I, Penn
LZ, et al: Integrin alpha 11 regulates IGF2 expression in
fibroblasts to enhance tumorigenicity of human non-small-cell lung
cancer cells. Proc Natl Acad Sci USA. 104:11754–11759. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu P, Wang Y, Wu Y, Jia Z, Song Y and
Liang N: Expression and prognostic analyses of ITGA11, ITGB4 and
ITGB8 in human non-small cell lung cancer. PeerJ. 7:e82992019.
View Article : Google Scholar :
|
|
47
|
Qi L, Gao C, Feng F, Zhang T, Yao Y, Wang
X, Liu C, Li J, Li J and Sun C: MicroRNAs associated with lung
squamous cell carcinoma: New prognostic biomarkers and therapeutic
targets. J Cell Biochem. 120:18956–18966. 2019. View Article : Google Scholar : PubMed/NCBI
|
